In the Ever-Shifting Diabetes Device Market, Flexibility and Focus Are Key
Medtronic’s plan to exit the diabetes device market via spin-off could have major implications for the competitive landscape. But even though the landscape is shifting, growth indicators remain strong as pump competitors Insulet and Tandem Diabetes Care make inroads into type 2 diabetes, Dexcom and Abbott tap new opportunities for CGMs, and newcomers line up with device innovations of their own.
Read Article